Skip to main content
Menu

Explore a Multitude of Research Samples at NCRAD

At NCRAD, we take pride in offering a wide range of biospecimens—over 370,000 samples from over 118,000 participants—that can help answer your most pressing research questions. We also employ rigorous quality control measures to maintain the highest standards.

To ensure that researchers have access to the most accurate information, NCRAD continually updates its database with new information. Therefore, we encourage you to request an updated set of variables prior to publication and implementation of analysis involving samples acquired from the repository. Although NCRAD makes every effort to verify all data and information, it cannot be held responsible for any errors or omissions in the distributed data.

Find Samples for Your Research

Researchers can request to access NCRAD's diverse repository of samples, including 12 sample types from 17 cohorts.

Approved researchers can query the online biospecimen catalogs to explore the range of biospecimens at NCRAD.

Available Samples

4RTNI-2

Population: CBD, PSP, o/vPSP, or healthy controls

Genomic DNARNAPlasmaSerumPBMCCSF
90+

Population: People aged 90 years and older

Genomic DNA
ADNI

Population: AD Cases, Controls, MCI

Genomic DNACell line DNARNAPlasmaLCLs
AA Genetics

Population: AD Cases, Controls

Cell line DNALCLs
ABC-DS

Population: Adults with Down Syndrome and Healthy Controls

Genomic DNAPlasmaSerum
ADRCs

Population: AD and other dementia cases, Controls, MCI

Genomic DNACell line DNARNAPlasmaSerumPBMCCSF
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration ALLFTD

Population: ARTFL: FTLD syndrome cases and healthy family members. LEFFTDS: FTLD family study with known genetic mutations (symptomatic and asymptomatic family members)

Genomic DNARNAPlasmaSerumPBMCCSF
ANGI

Population: Medicare beneficiaries age 65 and older with measurable cognitive deficits

Genomic DNA
API Generation Program

Population: Individuals who carry one of two copies of the high-risk gene apolipoproten E e4 (APOE4)

Genomic DNAPlasmaSerumCSF
API-ADAD

Population: PSEN1 E280A mutation carriers meeting study eligibility criteria were randomized to one of two treatment groups: crenezumab or placebo, both administered SC at a research site every 2 weeks.

Genomic DNARNAPlasmaSerumCSF
DIAN

Population: Early Onset AD Families with known mutations

Cell line DNALCLs
DMDC (Duke Memory Disorders Clinic)

Population: AD, and other dementia cases, Controls, MCI

Genomic DNAPlasma
GEMS

Population: Dementia prevention

Genomic DNAPlasmaSerum
GIFT

Population: AD, FTD, Controls

Genomic DNACell line DNALCLs
The Gift of Life Collection

Population: Individuals with neurodegenerative disease enrolled in the Gift to Life Outpatient Autopsy Planning Program

Fixed Brain Tissue
Indianapolis-Ibadan

Population: Elderly African Americans from Indianapolis, Yoruba living in Ibadan

Genomic DNACell line DNAPlasmaLCLs
iPSC Initiative

Population: ADRD and controls

iPSCFibroblasts
LEADS

Population: Adults with younger-onset Alzheimer's disease, cognitively impaired individuals without Alzheimer's disease, and cognitively unimpaired individuals

Genomic DNARNAPlasmaPBMCSerumCSF
LIFE-DSR

Population: Adults with Down Syndrome

Genomic DNARNAPlasmaPBMCCSF-PELLETCSF
NCRAD Family

Population: AD and other dementia families

Genomic DNACell line DNALCLsPBMCFixed Brain TissueFrozen Brain Tissue
NIA-AD-FBS

Population: Late Onset AD Families, Controls

Genomic DNACell line DNAPlasmaLCLsPBMC
Wisconsin Registry for Alzheimer’s Prevention (WRAP)

Population: Longitudinal study of individuals at risk for Alzheimer's disease

Genomic DNAPlasmaPMBCSerumCSF

Getting Started

Accessing samples from NCRAD is a straightforward process. Step-by-step guidance is available to assist you through the process. Ready to begin?

View sample application process